Inhaled long-acting β2 -agonist: aerosol particle size and bronchodilator response Source: Eur Respir J 2005; 26: Suppl. 49, 126s Year: 2005
Effect of fine particle mass (FPM) on the bronchodilator and bronchoprotective properties of salmeterol Source: Eur Respir J 2001; 18: Suppl. 33, 101s Year: 2001
Effect of inhaled corticosteroids over glucose metabolism Source: Eur Respir J 2002; 20: Suppl. 38, 303s Year: 2002
Effect of systemic and extra-fine particle inhaled corticosteroids on corrected alveolar nitric oxide (CANO) in COPD Source: Annual Congress 2011 - Drug delivery and pharmacokinetics I Year: 2011
Comparison of long-acting inhaled beta2–agonists plus inhaled steroids versus increasing dose of inhaled steroids on exhaled nitric oxide among asthmatic children poorly controlled Source: Eur Respir J 2005; 26: Suppl. 49, 617s Year: 2005
Dose-response effect of small particle vs standard size particle inhaled corticosteroids on severe asthma exacerbations by sex Source: International Congress 2015 – Management of asthma and other respiratory diseases in primary care Year: 2015
Effect of breath-actuated mechanism on the emitted particle characteristics and lung deposition of a fixed combination drug Source: International Congress 2017 – Inhalers and their use Year: 2017
Effects of montelukast on tapering inhaled corticosteroids in patients with asthma Source: Eur Respir J 2002; 20: Suppl. 38, 407s Year: 2002
Effects of montelukast on tapering inhaled corticosteroids in patients with asthma Source: Eur Respir J 2001; 18: Suppl. 33, 260s Year: 2001
Estimation of risk of osteoporosis based on inhaled and oral corticosteroids Source: Eur Respir J 2002; 20: Suppl. 38, 409s Year: 2002
Protective effect of inhaled glucocorticosteroids on COPD model. Source: Virtual Congress 2020 – Mechanistic insight into lung injury and repair Year: 2020
Effect of montelukast added to inhaled steroids on exhaled NO in asthmatic children Source: Eur Respir J 2001; 18: Suppl. 33, 40s Year: 2001
Effect of inhaled fluticasone poprionate and repeated short courses of oral corticosteroid on bone turnover in asthmatic children Source: Annual Congress 2008 - Drug therapy and assessment of control in childhood asthma Year: 2008
Reducing the dose of inhaled corticosteroids (ICS) under therapy with montelukast in stable asthma: effects on lung function and inflammation Source: Eur Respir J 2001; 18: Suppl. 33, 261s Year: 2001
Effect of once-daily inhaled glucocorticosteroid administration on exhaled nitric oxide in controlled asthma patients Source: Annual Congress 2008 - Pathogenesis and treatment of asthma and COPD Year: 2008
Effects of inhaled corticosteroids on asthmatic inflammation: The FeNOtype trial Source: Annual Congress 2012 - Asthma treatment: efficacy and safety Year: 2012
Impact of the combination therapy: inhaled corticosteroid and long-acting beta agonists in the prescription pattern of inhaled corticosteroids Source: Annual Congress 2007 - Respiratory issues in primary care Year: 2007
Effect of inhaled corticosteroid on air trapping in asthma: a CT scan approach Source: Eur Respir J 2004; 24: Suppl. 48, 68s Year: 2004
Effects of inhaled corticosteroids on growth in asthmatic children: A comparision of fluticasone propianate with budesonide Source: Eur Respir J 2003; 22: Suppl. 45, 133s Year: 2003
Concomitant use of low-dose inhaled corticosteroids and a long-acting bronchodilatator visavi doubling the dose of inhaled corticosterod in asthma patients Source: Eur Respir J 2001; 18: Suppl. 33, 98s Year: 2001